TITLE

Therapeutic trial of growth hormone releasing factor in HIV patients

AUTHOR(S)
Winslow, Dean L.
PUB. DATE
April 2008
SOURCE
AIDS Alert;Apr2008, Vol. 23 Issue 4, p45
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This multicenter, randomized, placebo-controlled trial of a synthetic GHRH analogue, tesamorelin (1-44 amino acids from the amino terminal of GHRH with a trans-3-hexenoyl group added to the amino terminal to increase the half-life over native GHRH), randomized 412 patients (86% male) to daily subcutaneous tesamorelin vs placebo for 26 weeks. Inclusion criteria included the receipt of at least 8 weeks prior antiretroviral (ARV) therapy and excessive abdominal visceral fat, as defined by various objective morphometric criteria. Use of stable lipid lowering regimen and testosterone replacement within 3 and 6 months of entry, respectively, was permitted. The tesamorelin regimen was well-tolerated, with only a modest increase in treatment related side effects seen in the tesamorelin arm. Peripheral edema, myalgia, hypoesthesia, paresthesia, rash, and injection site reactions were the only remarkable events that seemed to be associated with active drug, but all of these were encountered in less than 10% of patients. Bottom line results showed that tesamorelin therapy resulted in a 15.2% decrease in abdominal visceral fat vs an increase of 5% in the placebo group. Serum triglycerides decreased by 50 mg/dL in the tesamorelin group vs an increase of 9 mg/dL in the placebo group. Similarly, the total/HDL cholesterol ratio decreased by 0.31 in the treated vs increased by 0.21 in the placebo group. Levels of insulin-like growth factor (IGF-I), which mediates the effect of hGH on tissue, increased by 81% in the tesamorelin group and decreased by 5% in the placebo group. No differences in glycemic measurements were observed between the groups.
ACCESSION #
31655696

 

Related Articles

  • Metabolic Effects of a Growth Hormone�Releasing Factor in Patients with HIV. Falutz, Julian; Allas, Soraya; Blot, Koenraad; Potvin, Diane; Kotler, Donald; Somero, Michael; Berger, Daniel; Brown, Stephen; Richmond, Gary; Fessel, Jeffrey; Turner, Ralph; Grinspoon, Steven // New England Journal of Medicine;12/6/2007, Vol. 357 Issue 23, p2359 

    Background: Visceral adipose tissue accumulates during antiretroviral therapy in many patients who are infected with the human immunodeficiency virus (HIV); this process is associated with an increased cardiovascular risk. We assessed the use of a growth hormone�releasing factor analogue,...

  • How kids sprout up. Weeks, Janet // Parenting;Dec97/Jan98, Vol. 11 Issue 10, p35 

    Examines how the growth hormones work in kids. Information on the release of higher amounts of growth hormones at night; Discussion on the unique pattern of growth in each child; Views of assistant professor of pediatrics, Jorge Daaboul. INSET: See how much they've grown..

  • Literature reviews: Pediatric endocrinology. Ponder, Stephen W.; Lampe, John B. // Clinical Pediatrics;Sep1995, Vol. 34 Issue 9, p510 

    Presents a summary and commentary on the study `The Growth-Hormone-Releasing Activity of Hexarelin, a New Synthetic Hexapeptide in Short Normal and Obese Children and in Hypopituitary Subjects,' by S. Loche P. Cambiaso, D. Carta et al. which was published in the 1995 issue of the `Journal of...

  • Growth hormone releasing factor: comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapy. Grossman, A.; Lytras, N.; Savage, M.O.; Wass, J.A.H.; Coy, D.H.; Rees, Lesley H.; Jones, A.E.; Besser, G.M. // British Medical Journal (Clinical Research Edition);6/16/1984, Vol. 288 Issue 6433, p1785 

    Investigates the human pancreatic growth hormone factor (hpGHRF) in London, England. Effect of the hormone on both normal subjects and patients with growth hormone deficiency; Administration of the hormone on patients with prolactinomas; Importance of hpGHRF testing.

  • SRF.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2189 

    An encyclopedia entry for "SRF," which refers to somatotropin releasing factor, is presented.

  • THGRF PROMISING TO BENEFIT COPD PATIENTS WITH MUSCLE WASTING.  // Worldwide Biotech;Dec2003, Vol. 15 Issue 12, p3 

    Presents a study that examined the efficacy and safety of ThGRF, a stabilized analogue of the growth hormone-releasing factor, on body composition, functional status, respiratory function and quality of life in patients suffering from chronic wasting or muscle depletion in Canada and Europe.

  • Maximal secretory capacity of somatotrope cells in obesity: comparison with GH deficiency. Maccario, M; Valetto, M R; Savio, P; Aimaretti, G; Baffoni, C; Procopio, M; Grottoli, S; Oleandri, S E; Arvat, E; Ghigo, E // International Journal of Obesity & Related Metabolic Disorders;Jan1997, Vol. 21 Issue 1, p27 

    OBJECTIVE: To evaluate the maximal secretory capacity of somatotrope cells in obesity and to compare it with that in hypopituitaric patients with GH deficiency. DESIGN: Stimulation with GHRH. (1 μg/kg iv) combined with arginine (ARG, 0.5 g/kg iv), which strongly potentiates the GH response to...

  • Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly. Penny, Elizabeth S.; Penman, Erica; Price, Janet; Rees, Lesley H.; Sopwith, A.M.; Wass, J.A.H.; Lytras, N.; Besser, G.M. // British Medical Journal (Clinical Research Edition);8/25/1984, Vol. 289 Issue 6443, p453 

    Examines the circulating growth hormone releasing factor (GRF) concentrations in patients with and without acromegaly in Great Britain. Measurement by radioimmunoassay; Evaluation of GRF concentrations in plasma samples;.

  • Growth hormone naturally GH-releasing nutrients. Klatz, Ronald; Kahn, Carol // Total Health;May/Jun97, Vol. 19 Issue 2, p28 

    Focuses on the human growth hormone (HGH) which is the ultimate anti-aging therapy. Caution of using growth hormone (GH) releasers; Facts about amino acids that induce growth hormone secretion; Anti-aging benefits of amino acids; Clinical usage and possible side effects of these amino acids. ...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics